Cargando…
Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects
Neoantigens are abnormal proteins produced by genetic mutations in somatic cells. Because tumour neoantigens are expressed only in tumour cells and have immunogenicity, they may represent specific targets for precision immunotherapy. With the reduction in sequencing cost, continuous advances in arti...
Autores principales: | Gao, Lei, Zhang, Anqi, Yang, Fuyuan, Du, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416402/ https://www.ncbi.nlm.nih.gov/pubmed/36016159 http://dx.doi.org/10.3390/vaccines10081272 |
Ejemplares similares
-
Current landscape of clinical trials for HPV-positive head and neck squamous cell carcinoma (HNSCC)
por: Bteich, Yara T, et al.
Publicado: (2022) -
Differential expression profiling of head and neck squamous cell carcinoma (HNSCC)
por: Lemaire, F, et al.
Publicado: (2003) -
Comprehensive Genomic Review of TCGA Head and Neck Squamous Cell Carcinomas (HNSCC)
por: Pérez Sayáns, Mario, et al.
Publicado: (2019) -
Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma
por: Bann, Darrin V., et al.
Publicado: (2016) -
Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck
por: Xu, Qiang, et al.
Publicado: (2020)